ES2230337T3 - Derivados de oxindol. - Google Patents

Derivados de oxindol.

Info

Publication number
ES2230337T3
ES2230337T3 ES01950642T ES01950642T ES2230337T3 ES 2230337 T3 ES2230337 T3 ES 2230337T3 ES 01950642 T ES01950642 T ES 01950642T ES 01950642 T ES01950642 T ES 01950642T ES 2230337 T3 ES2230337 T3 ES 2230337T3
Authority
ES
Spain
Prior art keywords
quinolin
pyrrole
dihydro
methyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01950642T
Other languages
English (en)
Spanish (es)
Inventor
Scott Howard GlaxoSmithKline DICKERSON
David Harold GlaxoSmithKline DREWRY
James Andrew GlaxoSmithKline LINN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ES2230337T3 publication Critical patent/ES2230337T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES01950642T 2000-09-01 2001-06-28 Derivados de oxindol. Expired - Lifetime ES2230337T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23024100P 2000-09-01 2000-09-01
US230241P 2000-09-01

Publications (1)

Publication Number Publication Date
ES2230337T3 true ES2230337T3 (es) 2005-05-01

Family

ID=22864461

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01950642T Expired - Lifetime ES2230337T3 (es) 2000-09-01 2001-06-28 Derivados de oxindol.

Country Status (8)

Country Link
US (1) US6720332B2 (enExample)
EP (1) EP1313732B1 (enExample)
JP (1) JP2004508372A (enExample)
AT (1) ATE281455T1 (enExample)
AU (1) AU2001271611A1 (enExample)
DE (1) DE60106947T2 (enExample)
ES (1) ES2230337T3 (enExample)
WO (1) WO2002020524A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE420636T1 (de) * 1999-05-19 2009-01-15 Painceptor Pharma Corp Hemmer der protonenabhängigen kationenkanäle und deren verwendung in der behandlung von ischemiebedingten erkrankungen
KR20060111716A (ko) 2002-01-22 2006-10-27 워너-램버트 캄파니 엘엘씨 2-(피리딘-2-일아미노)-피리도[2,3-ｄ]피리미딘-7-온
PL1648889T3 (pl) * 2003-07-11 2009-03-31 Warner Lambert Co Sól izetionian selektywnego inhibitora CDK4
EP1699477A2 (en) * 2003-12-11 2006-09-13 Theravance, Inc. Compositions for use in the treatment of mutant receptor tyrosine kinase driven cellular proliferative diseases
US7304074B2 (en) * 2005-04-05 2007-12-04 Hoffmann-La Roche Inc. Substituted 1,5-naphthyridine azolinones
EP2580320B1 (en) 2010-06-14 2018-08-01 The Scripps Research Institute Reprogramming of cells to a new fate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9716557D0 (en) * 1997-08-06 1997-10-08 Glaxo Group Ltd Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity
GB9718913D0 (en) 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
GB9904933D0 (en) 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
WO2002020524A1 (en) 2002-03-14
ATE281455T1 (de) 2004-11-15
AU2001271611A1 (en) 2002-03-22
JP2004508372A (ja) 2004-03-18
US6720332B2 (en) 2004-04-13
US20030195189A1 (en) 2003-10-16
EP1313732B1 (en) 2004-11-03
DE60106947D1 (de) 2004-12-09
EP1313732A1 (en) 2003-05-28
DE60106947T2 (de) 2005-11-10

Similar Documents

Publication Publication Date Title
DE69824014T2 (de) Substituierte oxindolderivate als proteintyrosinkinase- und als protein-serin/threoninkinaseinhibitoren
DE69836332T2 (de) Benzyliden-1,3-dihydro-indol-2-on-derivate als inhibitoren von rezeptor tyrosin kinasen, insbesondere von raf kinasen
CN107889488B (zh) 咪唑酮基喹啉和其作为atm激酶抑制剂的用途
KR102399206B1 (ko) 이소퀴놀린-3-일 카르복스아마이드 및 이의 제제와 용도
ES2199156T3 (es) Derivados de aza-oxindol sustituidos.
ES2711777T3 (es) Indazol-3-carboxamidas y su uso como inhibidores de la ruta de señalización de Wnt/b-catenina
TWI458723B (zh) １，２－雙取代雜環化合物
EP3087070B1 (en) Pyrazolo[1,5-a]pyridine derivatives and methods of their use
ES2387780T3 (es) Preparación de azabencimidazoles 1,6-disustituidos como inhibidores de quinasas
US20200299263A1 (en) Isoquinolin-3-yl carboxamides and preparation and use thereof
CA3121236A1 (en) 2-oxoquinazoline derivatives as methionine adenosyltransferase 2a inhibitors
CN102574842B (zh) 用于抑制pi3激酶的吡啶基咪唑酮衍生物
US7723347B2 (en) Substituted phenylamino-pyrimidines
JP6827954B2 (ja) ３−（１ｈ−ベンズイミダゾール−２−イル）−１ｈ−ピリジン−２−オン誘導体
EP1430053B1 (en) AZAOXOINDOLE DERIVATIVES AS Trk PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND CHRONIC PAIN
BG65566B1 (bg) Производни на имидазо[1,2-a] пиридин и пиразоло[2,3-a]пиридин
PT2017278T (pt) Derivado de dihidropirazolopirimidinona
WO2019079626A1 (en) 6- (HETEROARYL 5-CHAIN) ISOQUINOLIN-3-YL CARBOXAMIDES, THEIR PREPARATION AND THEIR USE
JP6062432B2 (ja) プロテインキナーゼ阻害薬用スピロ環状分子
JP2020530020A (ja) Ｃｄｋ８／１９阻害薬としての新規ヘテロ環式化合物
CN106459043A (zh) 萘啶二酮衍生物
ES2230337T3 (es) Derivados de oxindol.
JP6847942B2 (ja) 二環式複素環式誘導体
JP2007511571A (ja) 癌およびアテローム性動脈硬化症のような疾患の治療において有用な置換イソキノリン
ES2371928T3 (es) Nuevos aza-heterociclos que actúan como inhibidores de la quinasa.